Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-((2R,6S,9S,11R,12R,14aS,15S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,12,15-tetrahydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl)-4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzamide
ID: ALA2387201
PubChem CID: 71624839
Max Phase: Preclinical
Molecular Formula: C55H69N9O19
Molecular Weight: 1160.20
Molecule Type: Unknown
Associated Items: